Drug search by name

Filgrastim-aafi Intravenous, Subcutaneous and Myeloid tumors

Generic Name: filgrastim
Dosage Forms: n.a.
Other Brand Names: Neupogen , Neupogen SingleJect, Nivestym , Zarxio

Result of checking the interaction of drug Filgrastim-aafi Intravenous, Subcutaneous and disease Myeloid tumors for safety when used together.

Check result:

Filgrastim-aafi Intravenous, Subcutaneous <> Myeloid tumors

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Colony stimulating factors primarily stimulates the proliferation of neutrophils but may also, theoretically, enhance tumor growth, particularly in myeloid malignancies. Therapy with these drugs should be administered cautiously in patients with myeloid tumors. Additionally, if used for PBPC (peripheral blood progenitor cell) collection in such patients, tumor cells may be released from the marrow and collected in the leukapheresis product. The effect of reinfusion of tumor cells is uncertain at this time.

References: